Randomized, double-blind, placebo-controlled, international trial fo the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

EJ Topol; D Easton; RA Harrington; P Amarenco; RM Califf; C Graffagnino; S Davis; HC Diener; J Ferguson; D Fitzgerald; J Granett; A Shuaib; Peter Koudstaal; P Theroux; F van der Werf; K Sigmon; K Pieper; M Vallee; JT Willerson

doi:10.1161/01.CIR.0000084501.48570.F6

Randomized, double-blind, placebo-controlled, international trial fo the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

EJ Topol, D Easton, RA Harrington, P Amarenco, RM Califf, C Graffagnino, S Davis, HC Diener, J Ferguson, D Fitzgerald, J Granett, A Shuaib, Peter Koudstaal, P Theroux, F van der Werf, K Sigmon, K Pieper, M Vallee, JT Willerson

Neurology

Research output: Contribution to journal › Article › Academic › peer-review

201 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	399-406
Number of pages	8
Journal	Circulation
Volume	108
DOIs	https://doi.org/10.1161/01.CIR.0000084501.48570.F6
Publication status	Published - 2003

Access to Document

10.1161/01.CIR.0000084501.48570.F6

http://hdl.handle.net/1765/22493

Cite this

Topol, EJ., Easton, D., Harrington, RA., Amarenco, P., Califf, RM., Graffagnino, C., Davis, S., Diener, HC., Ferguson, J., Fitzgerald, D., Granett, J., Shuaib, A., Koudstaal, P., Theroux, P., van der Werf, F., Sigmon, K., Pieper, K., Vallee, M., & Willerson, JT. (2003). Randomized, double-blind, placebo-controlled, international trial fo the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation, 108, 399-406. https://doi.org/10.1161/01.CIR.0000084501.48570.F6

@article{71b7c356379844cab54c8170e04b60f0,

title = "Randomized, double-blind, placebo-controlled, international trial fo the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease",

author = "EJ Topol and D Easton and RA Harrington and P Amarenco and RM Califf and C Graffagnino and S Davis and HC Diener and J Ferguson and D Fitzgerald and J Granett and A Shuaib and Peter Koudstaal and P Theroux and {van der Werf}, F and K Sigmon and K Pieper and M Vallee and JT Willerson",

year = "2003",

doi = "10.1161/01.CIR.0000084501.48570.F6",

language = "Undefined/Unknown",

volume = "108",

pages = "399--406",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams & Wilkins",

}

Topol, EJ, Easton, D, Harrington, RA, Amarenco, P, Califf, RM, Graffagnino, C, Davis, S, Diener, HC, Ferguson, J, Fitzgerald, D, Granett, J, Shuaib, A, Koudstaal, P, Theroux, P, van der Werf, F, Sigmon, K, Pieper, K, Vallee, M & Willerson, JT 2003, 'Randomized, double-blind, placebo-controlled, international trial fo the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease', Circulation, vol. 108, pp. 399-406. https://doi.org/10.1161/01.CIR.0000084501.48570.F6

TY - JOUR

T1 - Randomized, double-blind, placebo-controlled, international trial fo the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

AU - Topol, EJ

AU - Easton, D

AU - Harrington, RA

AU - Amarenco, P

AU - Califf, RM

AU - Graffagnino, C

AU - Davis, S

AU - Diener, HC

AU - Ferguson, J

AU - Fitzgerald, D

AU - Granett, J

AU - Shuaib, A

AU - Koudstaal, Peter

AU - Theroux, P

AU - van der Werf, F

AU - Sigmon, K

AU - Pieper, K

AU - Vallee, M

AU - Willerson, JT

PY - 2003

Y1 - 2003

U2 - 10.1161/01.CIR.0000084501.48570.F6

DO - 10.1161/01.CIR.0000084501.48570.F6

M3 - Article

C2 - 12874182

SN - 0009-7322

VL - 108

SP - 399

EP - 406

JO - Circulation

JF - Circulation

ER -